Clinical Trials

New Search
Title   S1505: Combination Chemotherapy or Gemcitabine Hydrochloride and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
Disease/Condition   Pancreatic Cancer
Eligibility Criteria   Ages Eligible for Study: 18 Years to 75 Years (Adult, Senior) Genders Eligible for Study: Both Accepts Healthy Volunteers: No Click here for eligibility requirements
Principal┬áInvestigator   Lakshmi Rajdev, MD
Contact┬áName   Karen Fehn
Phone   (718) 405-8446
Contact Email
IRB/Protocol┬áNumber   IRB# 2016-6464
Status   Enrolling
Adult Clinical Trial   Yes
Pediatric Clinical Trial   No